
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Glucagon
Therapeutic Area : Endocrinology
Study Phase : Preclinical
Recipient : Xeris Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
LifeArc Makes Investment to Support Drug Discovery in Sub-Saharan Africa
Details : The collaboration aims for the development and commercialization of a glucagon product utilizing Xeris’ XeriSol™ technology for use in Beta Bionics’ proprietary bi-hormonal pump and pump systems.
Product Name : Ogluo
Product Type : Peptide, Unconjugated
Upfront Cash : Undisclosed
May 06, 2024
Lead Product(s) : Glucagon
Therapeutic Area : Endocrinology
Highest Development Status : Preclinical
Recipient : Xeris Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
